Research ArticleOriginal Research

A Predictive Equation to Guide Vitamin D Replacement Dose in Patients

Gurmukh Singh and Aaron J. Bonham
The Journal of the American Board of Family Medicine July 2014, 27 (4) 495-509; DOI: https://doi.org/10.3122/jabfm.2014.04.130306

References

  1. 1.↵
    Institute of Medicine, Food and Nutrition Board. Dietary reference intakes for calcium and vitamin D. Washington, DC: National Academy Press, 2010.
  2. 2.↵
    National Institutes of Health Office of Dietary Supplements. Vitamin D. Fact sheet for health professionals. Available from: http://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/. Reviewed June 24, 2011. Accessed May 16, 2014.
  3. 3.↵
    1. Holick MF,
    2. Binkley NC,
    3. Bischoff-Ferrari HA,
    4. et al
    . Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. Available from: https://www.endocrine.org/∼/media/endosociety/Files/Publications/Clinical%20Practice%20Guidelines/FINAL-Standalone-Vitamin-D-Guideline.pdf/. Accessed May 16, 2014.
  4. 4.↵
    1. Garland CF,
    2. French CB,
    3. Baggerly LL,
    4. Heaney RP
    . Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention. Anticancer Res 2011;31:617–22.
    OpenUrl
  5. 5.↵
    1. Hossein-Nezhad A,
    2. Holick MF
    . Vitamin D for health: a global perspective. Mayo Clin Proc 2013;88:720–55.
    OpenUrlCrossRefPubMedWeb of Science
  6. 6.↵
    1. Ross AC,
    2. Taylor CL,
    3. Yaktine AL,
    4. DelValle HB
    , eds; Committee to Review Dietary Reference Intakes for Vitamin D and Calcium; Institute of Medicine. Dietary reference intakes for calcium and vitamin D (2011). Available from: http://www.nap.edu/catalog.php?record_id=13050. Accessed May 16, 2014.
  7. 7.↵
    1. Vieth R
    . Why the minimum desirable serum 25-hydroxyvitamin D level should be 75 nmol/L (30 ng/ml). Best Pract Res Clin Endocrinol Metab 2011;25:681–91.
    OpenUrlCrossRef
  8. 8.↵
    1. Rizzoili R,
    2. Boonen S,
    3. Brandi ML,
    4. et al
    . Vitamin D supplementation in elderly or postmenopausal women; a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and osteoarthritis (ESCEO). Curr Med Res Opin 2013;29:305–13.
    OpenUrlPubMed
  9. 9.↵
    1. Holick MF,
    2. Binkley NC,
    3. Bischoff-Ferrari HA,
    4. et al
    . Guidelines for preventing and treating vitamin D deficiency and insufficiency revisited. J Clin Endocrinol Metab 2012;97:1153–8.
    OpenUrlCrossRefPubMedWeb of Science
  10. 10.↵
    1. Forrest KY,
    2. Stuhldreher WL
    . Prevalence and correlates of vitamin D deficiency in US adults. Nutr Res 2011;31:48–54.
    OpenUrlCrossRefPubMed
  11. 11.↵
    National Institutes of Health Office of Dietary supplements. Dietary supplement fact sheet: vitamin D. June 24, 2011.
  12. 12.↵
    1. Cranney C,
    2. Horsely T,
    3. O'Donnell S,
    4. et al
    . Effectiveness and safety of vitamin D. Evidence report/technology assessment no. 158. AHRQ publication no. 07-E013. Rockville, MD: Agency for Healthcare Research and Quality; 2007.
  13. 13.↵
    1. Shils ME,
    2. Shike M,
    3. Ross AC,
    4. Caballero B,
    5. Cousins RJ
    1. Holick MF
    . Vitamin D. In: Shils ME, Shike M, Ross AC, Caballero B, Cousins RJ , eds. Modern nutrition in health and disease, 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2006.
  14. 14.↵
    1. Bowman BA,
    2. Russell RM
    1. Norman AW,
    2. Henry HH
    . Vitamin D. In: Bowman BA, Russell RM , eds. Present knowledge in nutrition, 9th ed. Washington DC: ILSI Press; 2006.
  15. 15.↵
    1. McAlindon TE,
    2. Felson DT,
    3. Zhang Y,
    4. et al
    . Relation of dietary intake and serum levels of vitamin D to progression of osteoarthritis of the knee among participants in the Framingham study. Ann Intern Med 1996;125:353–9.
    OpenUrlCrossRefPubMedWeb of Science
  16. 16.↵
    1. Reichrath J,
    2. Nürnberg B
    . Cutaneous vitamin D synthesis versus skin cancer development: the Janus faces of solar UV-radiation. Dermatoendocrinol 2009;1:253–61.
    OpenUrlCrossRefPubMed
  17. 17.↵
    U.S. Department of Agriculture, Agricultural Research Service. USDA National Nutrient Database for Standard Reference, release 24. 2011. Available from: http://www.ars.usda.gov/Services/docs.htm?docid=22808. Accessed May 29, 2014.
  18. 18.↵
    1. Singh G
    . Prevalence and implications of vitamin D deficiency in applicants for insurance. J Insurance Med. In press.
  19. 19.↵
    1. Wharton B,
    2. Bishop N
    . Rickets. Lancet 2003;362:1389–400.
    OpenUrlCrossRefPubMedWeb of Science
  20. 20.↵
    1. Shah M,
    2. Salhab N,
    3. Patterson D,
    4. Seikaly MG
    . Nutritional rickets still afflict children in north Texas. Tex Med 2000;96:64–8.
    OpenUrlPubMed
  21. 21.↵
    1. Collins N,
    2. Maher J,
    3. Cole M,
    4. et al
    . A prospective study to evaluate the dose of vitamin D required to correct low 25-hydroxyvitamin D levels, calcium, and alkaline phosphatase in patients at risk of developing antiepileptic drug-induced osteomalacia. Q J Med 1991;78:113–22.
    OpenUrlAbstract/FREE Full Text
  22. 22.↵
    1. Semba RD,
    2. Houston DK,
    3. Ferrucci L,
    4. et al
    . Low serum 25-hydroxyvitamin D concentrations are associated with greater all-cause mortality in older community-dwelling women. Nutr Res 2009;29:525–30.
    OpenUrlCrossRefPubMedWeb of Science
  23. 23.↵
    1. Dobnig H,
    2. Pilz S,
    3. Scharnagl H,
    4. et al
    . Independent association of low serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D levels with all-cause and cardiovascular mortality. Arch Intern Med 2008;168:1340–9.
    OpenUrlCrossRefPubMedWeb of Science
  24. 24.↵
    1. Holick MF
    . Sunlight “D”ilemma: risk of skin cancer or bone disease and muscle weakness. Lancet 2001;357:4–6.
    OpenUrlCrossRefPubMedWeb of Science
  25. 25.↵
    1. Prabhala A,
    2. Garg R,
    3. Dandona P
    . Severe myopathy associated with vitamin D deficiency in western New York. Arch Intern Med 2000;160:1199–203.
    OpenUrlCrossRefPubMedWeb of Science
  26. 26.↵
    1. Prince RL,
    2. Austin N,
    3. Devine A,
    4. et al
    . Effects of ergocalciferol added to calcium on the risk of falls in elderly high-risk women. Arch Intern Med 2008;168:103–8.
    OpenUrlCrossRefPubMedWeb of Science
  27. 27.↵
    1. Ahmed W,
    2. Khan N,
    3. Glueck CJ,
    4. et al
    . Low serum 25 (OH) vitamin D levels (<32 ng/mL) are associated with reversible myositis-myalgia in statin-treated patients. Transl Res 2009;153:11–6.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Cava RC,
    2. Javier AN
    . Vitamin D deficiency. N Engl J Med 2007;357:1981.
    OpenUrlPubMedWeb of Science
  29. 29.↵
    1. Holick MF
    . Vitamin D deficiency. N Engl J Med 2007;357:266–81.
    OpenUrlCrossRefPubMedWeb of Science
  30. 30.↵
    1. Adams JS,
    2. Hewison M
    . Update in vitamin D. J Clin Endocrinol Metab 2010;95:471–8.
    OpenUrlCrossRefPubMedWeb of Science
  31. 31.↵
    1. Rosen CJ,
    2. Adams JS,
    3. Bikle DD,
    4. et al
    . The non-skeletal effects of vitamin D: an endocrine society scientific statement. Endocr Rev 2012;33:456–92.
    OpenUrlCrossRefPubMedWeb of Science
  32. 32.↵
    1. Wimalawansa SJ
    . Vitamin D: an essential component for skeletal health. Ann N Y Acad Sci 2011;1240:E1–12.
    OpenUrlPubMed
  33. 33.↵
    1. Grant WB,
    2. Cross HS,
    3. Garland CF,
    4. et al
    . Estimated benefit of increased vitamin D status in reducing the economic burden of disease in Western Europe. Prog Biophys Mol Biol 2009;99:104–13.
    OpenUrlCrossRefPubMedWeb of Science
  34. 34.↵
    1. Grant WB
    . An estimate of the global reduction in mortality rates through doubling vitamin D levels. Eur J Clin Nutr 2011;65:1016–26.
    OpenUrlCrossRefPubMedWeb of Science
  35. 35.↵
    1. Herr C,
    2. Greulich T,
    3. Koczulla R,
    4. et al
    . The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer. Respir Res 2011;12:31.
    OpenUrlCrossRefPubMed
  36. 36.↵
    1. Afzal S,
    2. Bojesen SE,
    3. Nordestgaard BG
    . Low plasma 25-hydroxvitamin D and risk of tobacco-related cancer. Clin Chem 2013;59:771–80.
    OpenUrlAbstract/FREE Full Text
  37. 37.↵
    1. Giovannucci E,
    2. Liu Y,
    3. Rimm EB,
    4. et al
    . Prospective study of predictors of vitamin D status and cancer incidence and mortality in men. J Natl Cancer Inst 2006;98:451–9.
    OpenUrlAbstract/FREE Full Text
  38. 38.↵
    1. Trummer O,
    2. Pilz S,
    3. Hoffman MM,
    4. et al
    . Vitamin D and mortality: a Mendelian randomization study. Clin Chem 2013;59:793–7.
    OpenUrlAbstract/FREE Full Text
  39. 39.↵
    1. Gross MD
    . Vitamin D and calcium in the prevention of prostate and colon cancer: new approaches for the identification of needs. J Nutr 2005;135:326–31.
    OpenUrlAbstract/FREE Full Text
  40. 40.↵
    1. Oh J,
    2. Weng S,
    3. Felton SK,
    4. et al
    . 1,25 (OH)2 Vitamin D inhibits foam cell formation and suppresses macrophage cholesterol uptake in patients with type 2 diabetes mellitus. Circulation 2009;120:687–98.
    OpenUrlAbstract/FREE Full Text
  41. 41.↵
    1. Pittas AG,
    2. Lau J,
    3. Hu FB,
    4. Dawson-Hughes B
    . The role of vitamin d and calcium in type 2 diabetes. A systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017–29.
    OpenUrlCrossRefPubMedWeb of Science
  42. 42.↵
    1. Giovannucci E,
    2. Liu Y,
    3. Hollis BW,
    4. Rimm EB
    . 25-hydroxyvitamin D and risk of myocardial infarction in men. Arch Intern Med 2008;168:1174–80.
    OpenUrlCrossRefPubMedWeb of Science
  43. 43.↵
    1. Tomson J.,
    2. Emberson J,
    3. Hill M,
    4. et al
    . Vitamin D and risk of death from vascular and non-vascular causes in Whitehall study and meta-analysis of 12,000 deaths. Eur Heart J 2013;34:1365–74.
    OpenUrlAbstract/FREE Full Text
  44. 44.↵
    1. Freedman DM,
    2. Looker AC,
    3. Chang SC,
    4. Graubard BI
    . Prospective study of serum vitamin D and cancer mortality in the United States. J Natl Cancer Inst 2007;99:1594–602.
    OpenUrlAbstract/FREE Full Text
  45. 45.↵
    1. Autier P,
    2. Gandini S
    . Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials. Arch Intern Med 2007;167:1730–7.
    OpenUrlCrossRefPubMedWeb of Science
  46. 46.↵
    1. Gorham ED,
    2. Garland CF,
    3. Garland FC,
    4. et al
    . Optimal vitamin D status for colorectal cancer prevention: a quantitative meta analysis. Am J Prev Med 2007;32:210–6.
    OpenUrlCrossRefPubMedWeb of Science
  47. 47.↵
    1. Garland CF,
    2. Gorham ED,
    3. Mohr SB,
    4. et al
    . Vitamin D and prevention of breast cancer: pooled analysis. J Steroid Biochem Mol Biol 2007;103:708–11.
    OpenUrlCrossRefPubMedWeb of Science
  48. 48.↵
    1. Holick MF
    . Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease. Am J Clin Nutr 2004;80:1678S–88S.
    OpenUrlAbstract/FREE Full Text
  49. 49.↵
    1. Dietrich T,
    2. Joshipura KJ,
    3. Dawson-Hughes B,
    4. Bischoff-Ferrari HA
    . Association between serum concentrations of 25-hydroxyvitamin D3 and periodontal disease in the US population. Am J Clin Nutr 2004;80:108–13.
    OpenUrlAbstract/FREE Full Text
  50. 50.↵
    1. Lin J,
    2. Manson JE,
    3. Lee IM,
    4. et al
    . Intakes of calcium and vitamin D and breast cancer risk in women. Arch Intern Med 2007;167:1050–9.
    OpenUrlCrossRefPubMedWeb of Science
  51. 51.↵
    1. Liu S,
    2. Song Y,
    3. Ford ES,
    4. et al
    . Dietary calcium, vitamin D, and the prevalence of metabolic syndrome in middle-aged and older US women. Diabetes Care 2005;28:2926–32.
    OpenUrlAbstract/FREE Full Text
  52. 52.↵
    1. Mellibovsky L,
    2. Diez A,
    3. Perez-Vila E,
    4. et al
    . Vitamin D treatment in myelodysplastic syndromes. Br J Haematol 1998;100:516–20.
    OpenUrlCrossRefPubMed
  53. 53.↵
    1. Munger KL,
    2. Zhang SM,
    3. O'Reilly E,
    4. et al
    . Vitamin D intake and incidence of multiple sclerosis. Neurology 2004;62:60–5.
    OpenUrlCrossRef
  54. 54.↵
    1. Grant WB
    . A critical review of vitamin D and cancer: a report of the IARC Working Group. Dermatoendocrinol 2009;1:25–33.
    OpenUrlCrossRefPubMed
  55. 55.↵
    1. Dror Y,
    2. Giveon SM,
    3. Hoshen M,
    4. Feldhamer I,
    5. Balice RD,
    6. Feidman BS
    . Vitamin D levels for preventing acute coronary syndrome and mortality: Evidence of a non-linear association. J Clin Endocrinol Metab 2013;98:2160–7.
    OpenUrlCrossRefPubMedWeb of Science
  56. 56.↵
    1. Cook NR
    . Vitamin D and cancer: can we believe the evidence from observational studies? Clin Chem 2013;59:726–8.
    OpenUrlFREE Full Text
  57. 57.↵
    1. Eisman JA
    . When is a U-curve actually a J-curve? Is it really too much of a good thing? J Clin Endocrinol Metab 2013;98:1863–4.
    OpenUrl
  58. 58.↵
    1. Bolland MJ,
    2. Grey A,
    3. Gamble GD,
    4. Reid IR
    . The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis. Lancet Diabetes Endocrinol 2014;2:307–20.
    OpenUrlCrossRefPubMed
  59. 59.↵
    1. Ginde AA,
    2. Mansbach JM,
    3. Camargo CA
    . Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the third national health and nutrition examination survey. Arch Intern Med 2009;169:384–90.
    OpenUrlCrossRefPubMedWeb of Science
  60. 60.↵
    1. Hollis BW
    . Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D. J Nutr 2005;135:317–22.
    OpenUrlAbstract/FREE Full Text
  61. 61.↵
    Dietary reference intakes for calcium and vitamin D. Washington, DC: Institute of Medicine; 2010. Available from: http://www.iom.edu/∼/media/Files/Report%20Files/2010/Dietary-Reference-Intakes-for-Calcium-and-Vitamin-D/Vitamin%20D%20and%20Calcium%202010%20Report%20Brief.pdf. Accessed May 16, 2014.
  62. 62.↵
    1. Vieth R,
    2. Bischoff-Ferrari H,
    3. Boucher BJ,
    4. et al
    . The urgent need to recommend an intake of vitamin D that is effective. Am J Clin Nutr 2007;85:649–50.
    OpenUrlFREE Full Text
  63. 63.↵
    1. Wolpowitz D,
    2. Gilchrest BA
    . The vitamin D questions: how much do you need and how should you get it? J Am Acad Dermatol 2006;54:301–17.
    OpenUrlCrossRefPubMedWeb of Science
  64. 64.↵
    1. Demontiero O,
    2. Herrmann M,
    3. Duque G
    . Supplementation with vitamin D and calcium in long-term care residents. J Am Med Dir Assoc 2011;12:190–4.
    OpenUrlPubMed
  65. 65.↵
    Panel on Prevention of Falls in Older Persons, American Geriatrics Society, and British Geriatrics Society. Summary of the updated American Geriatrics Society/British Geriatrics Society clinical practice guideline for prevention of falls in older persons. J Am Geriatr Soc 2011;59:148–57.
    OpenUrlCrossRefPubMed
  66. 66.↵
    1. Danik JS,
    2. Manson JE
    . Vitamin D and cardiovascular disease. Curr Treat Options Cardiovasc Med 2012;14:414–24.
    OpenUrlCrossRefPubMed
  67. 67.↵
    1. Pornpoj P,
    2. Holick MF
    . Vitamin D supplementation: guidelines for subclinical deficiency. Curr Opinion in Gastroenterol 2012;28:139–50.
    OpenUrl
  68. 68.↵
    1. Heaney RP,
    2. Davies KM,
    3. Chen TC,
    4. Holick MF,
    5. Barger-Lux MJ
    . Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. Am J Clin Nutr 2003;77:204–10. Erratum in: Am J Clin Nutr 2003;78:1047.
    OpenUrlAbstract/FREE Full Text
  69. 69.↵
    1. Bailey RL,
    2. Dodd KW,
    3. Goldman JA,
    4. et al
    . Estimation of total usual calcium and vitamin D intakes in the United States. J Nutr 2010;140:817–22.
    OpenUrlAbstract/FREE Full Text
  70. 70.↵
    1. Jones G,
    2. Barker A
    . Reference intervals. Clin Biochem Rev 2008;29(Suppl 1):S93–7.
    OpenUrlPubMed
  71. 71.↵
    AGS releases consensus statement on vitamin D for prevention of falls and fractures in older adults. December 20, 2013. Available from: http://www.americangeriatrics.org/press/news_press_releases/2013_press_release_archive/id:4643. Accessed May 29, 2014.
  72. 72.↵
    1. Matsuoka LY,
    2. Ide L,
    3. Wortsman J,
    4. et al
    . Suncreens suppress cutaneous vitamin D3 synthesis. J Clin Endocrinol Metab 1987;64:1165–8.
    OpenUrlCrossRefPubMedWeb of Science
  73. 73.↵
    1. Dong Y,
    2. Stallmann-Jorgensen IS,
    3. Pollock,
    4. et al
    . A 16-week randomized clinical trial of 2000 international units daily vitamin D3 supplementation in black youth: 25-hydroxyvitamin D, adiposity, and arterial stiffness. J. Clin Endocrinol Metab 2010;95:4584–91.
    OpenUrl
  74. 74.↵
    1. Flegal KM,
    2. Carroll MD,
    3. Ogden CL,
    4. Johnson CL
    . Prevalence and trends in obesity among US adults, 1999–2000. JAMA 2002;288:1723–7.
    OpenUrlCrossRefPubMedWeb of Science
  75. 75.↵
    1. Holick MF,
    2. Binkley NC,
    3. Bischoff-Ferrari HA,
    4. et al
    ; Endocrine Society. Evaluation, treatment and prevention of vitamin D deficiency: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab 2011;96:1911–30.
    OpenUrlCrossRefPubMedWeb of Science
  76. 76.↵
    1. Drincic AT,
    2. Armas LA,
    3. Van Diest EE,
    4. Heaney RP
    . Volumetric dilution, rather than sequestration best explains the low vitamin D status of obesity. Obesity 2012;20:1444–8.
    OpenUrlPubMedWeb of Science
  77. 77.↵
    1. Heaney RP,
    2. Armas LA,
    3. French C
    . All-source basal vitamin D inputs are greater than previously thought and cutaneous inputs are smaller. J Nutr 2013;143:571–5.
    OpenUrlAbstract/FREE Full Text
  78. 78.↵
    1. Schwalfenberg GK,
    2. Genuis SJ
    . Vitamin D supplementation in a nursing home population. Mol Nutr Food Res 2010;54:1072–6.
    OpenUrlPubMedWeb of Science
  79. 79.↵
    1. Fitzmaurice G
    . A conundrum in the analysis of change. Nutrition 2001;17:360–1.
    OpenUrlCrossRefPubMedWeb of Science
  80. 80.↵
    1. Bikle DD,
    2. Gee E,
    3. Halloran B,
    4. Kowalski MA,
    5. Ryzen E,
    6. Haddad JG
    . Assessment of the free fraction of 25-hydroxyvitamin D in serum and its regulation by albumin and the vitamin D-binding protein. J Clin Endocrinol Metab 1986;63:954–9.
    OpenUrlCrossRefPubMedWeb of Science
  81. 81.↵
    1. Powe CE,
    2. Evans MK,
    3. Wegner J,
    4. et al
    . Vitamin D-binding protein and vitamin D status of black Americans and white Americans. N Engl J Med 2013;369:1991–2000.
    OpenUrlCrossRefPubMedWeb of Science
  82. 82.↵
    1. Gallagher JC,
    2. Sai A,
    3. Tmplin T,
    4. Smith L
    . Dose response to vitamin D supplementation in postmenopausal women. Ann Intern Med 2012;156:425–37.
    OpenUrlCrossRefPubMedWeb of Science
  83. 83.↵
    1. Cipriani C,
    2. Romagnoli E,
    3. Pepe J,
    4. et al
    . Long-term bioavailability after a single oral or intramuscular administration of 600,000 IU of ergocalciferol or cholecalciferol: implications for treatment and prophylaxis. J Clin Endocrinol Metab 2013;98:2709–15.
    OpenUrlCrossRefPubMed
  84. 84.↵
    1. de Jong A,
    2. Woods K,
    3. Van Gestel L,
    4. Suresh M,
    5. Porteous M
    . Vitamin D insufficiency in osteoporotic hip fracture patients: rapid substitution therapy with high dose oral cholecalciferol (vitamin D3). Acta Orthop Belg 2013;79:578–86.
    OpenUrlPubMed
  85. 85.↵
    1. Jeng L,
    2. Yamshchikov AV,
    3. Judd SE,
    4. et al
    . Alteration in vitamin D status and anti-microbial peptide levels in patients in the intensive care unit with sepsis. J Transl Med 2009;7:28.
    OpenUrlCrossRefPubMed
  86. 86.↵
    1. Bischoff-Ferrari HA,
    2. Willett WC,
    3. Orav EJ,
    4. et al
    . A pooled analysis of vitamin D dose requirement for fracture prevention. N Engl J Med 2012;367:40–9.
    OpenUrlCrossRefPubMedWeb of Science
Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools

Jump to section

Keywords